Annual EBITDA
$813.30 M
+$4.90 M+0.61%
31 December 2023
Summary:
West Pharmaceutical Services annual earnings before interest, taxes, depreciation & amortization is currently $813.30 million, with the most recent change of +$4.90 million (+0.61%) on 31 December 2023. During the last 3 years, it has risen by +$294.70 million (+56.83%). WST annual EBITDA is now -7.52% below its all-time high of $879.40 million, reached on 31 December 2021.WST EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
$205.40 M
+$36.30 M+21.47%
30 September 2024
Summary:
West Pharmaceutical Services quarterly earnings before interest, taxes, depreciation & amortization is currently $205.40 million, with the most recent change of +$36.30 million (+21.47%) on 30 September 2024. Over the past year, it has dropped by -$20.20 million (-8.95%). WST quarterly EBITDA is now -20.73% below its all-time high of $259.10 million, reached on 30 June 2022.WST Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
$744.40 M
-$20.20 M-2.64%
30 September 2024
Summary:
West Pharmaceutical Services TTM earnings before interest, taxes, depreciation & amortization is currently $744.40 million, with the most recent change of -$20.20 million (-2.64%) on 30 September 2024. Over the past year, it has dropped by -$56.10 million (-7.01%). WST TTM EBITDA is now -18.24% below its all-time high of $910.50 million, reached on 30 June 2022.WST TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
WST EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +0.6% | -8.9% | -7.0% |
| 3 y3 years | +56.8% | -3.5% | -7.7% |
| 5 y5 years | +130.1% | +122.5% | +89.8% |
WST EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -7.5% | +56.8% | -20.7% | +27.2% | -18.2% | +0.2% |
| 5 y | 5 years | -7.5% | +130.1% | -20.7% | +122.5% | -18.2% | +89.8% |
| alltime | all time | -7.5% | +3405.6% | -20.7% | +206.5% | -18.2% | +533.0% |
West Pharmaceutical Services EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $205.40 M(+21.5%) | $744.40 M(-2.6%) |
| June 2024 | - | $169.10 M(+2.7%) | $764.60 M(-6.4%) |
| Mar 2024 | - | $164.60 M(-19.8%) | $817.20 M(-3.2%) |
| Dec 2023 | $813.30 M(+0.6%) | $205.30 M(-9.0%) | $844.30 M(+5.5%) |
| Sept 2023 | - | $225.60 M(+1.8%) | $800.50 M(+7.7%) |
| June 2023 | - | $221.70 M(+15.6%) | $743.10 M(-4.8%) |
| Mar 2023 | - | $191.70 M(+18.7%) | $780.50 M(-3.5%) |
| Dec 2022 | $808.40 M(-8.1%) | $161.50 M(-4.0%) | $808.40 M(-6.6%) |
| Sept 2022 | - | $168.20 M(-35.1%) | $865.80 M(-4.9%) |
| June 2022 | - | $259.10 M(+18.0%) | $910.50 M(+1.9%) |
| Mar 2022 | - | $219.60 M(+0.3%) | $893.10 M(+1.6%) |
| Dec 2021 | $879.40 M(+69.6%) | $218.90 M(+2.8%) | $879.40 M(+9.1%) |
| Sept 2021 | - | $212.90 M(-11.9%) | $806.20 M(+11.7%) |
| June 2021 | - | $241.70 M(+17.4%) | $721.50 M(+18.3%) |
| Mar 2021 | - | $205.90 M(+41.3%) | $610.00 M(+17.6%) |
| Dec 2020 | $518.60 M(+28.5%) | $145.70 M(+13.7%) | $518.60 M(+8.3%) |
| Sept 2020 | - | $128.20 M(-1.5%) | $478.70 M(+8.1%) |
| June 2020 | - | $130.20 M(+13.7%) | $442.80 M(+5.3%) |
| Mar 2020 | - | $114.50 M(+8.2%) | $420.50 M(+4.2%) |
| Dec 2019 | $403.70 M(+14.2%) | $105.80 M(+14.6%) | $403.70 M(+2.9%) |
| Sept 2019 | - | $92.30 M(-14.5%) | $392.30 M(+0.8%) |
| June 2019 | - | $107.90 M(+10.4%) | $389.30 M(+5.4%) |
| Mar 2019 | - | $97.70 M(+3.5%) | $369.20 M(+4.4%) |
| Dec 2018 | $353.50 M(+8.1%) | $94.40 M(+5.7%) | $353.50 M(+2.3%) |
| Sept 2018 | - | $89.30 M(+1.7%) | $345.40 M(0.0%) |
| June 2018 | - | $87.80 M(+7.1%) | $345.40 M(+6.6%) |
| Mar 2018 | - | $82.00 M(-5.0%) | $324.00 M(-0.9%) |
| Dec 2017 | $326.90 M(+13.3%) | $86.30 M(-3.4%) | $326.90 M(+2.8%) |
| Sept 2017 | - | $89.30 M(+34.5%) | $318.00 M(+4.9%) |
| June 2017 | - | $66.40 M(-21.8%) | $303.10 M(-5.5%) |
| Mar 2017 | - | $84.90 M(+9.7%) | $320.90 M(+11.2%) |
| Dec 2016 | $288.60 M(+31.1%) | $77.40 M(+4.0%) | $288.60 M(+3.1%) |
| Sept 2016 | - | $74.40 M(-11.6%) | $280.00 M(+24.4%) |
| June 2016 | - | $84.20 M(+60.1%) | $225.00 M(+11.1%) |
| Mar 2016 | - | $52.60 M(-23.5%) | $202.50 M(-8.0%) |
| Dec 2015 | $220.10 M(-20.1%) | $68.80 M(+254.6%) | $220.10 M(+0.6%) |
| Sept 2015 | - | $19.40 M(-68.6%) | $218.70 M(-18.5%) |
| June 2015 | - | $61.70 M(-12.1%) | $268.20 M(-5.6%) |
| Mar 2015 | - | $70.20 M(+4.2%) | $284.20 M(+3.2%) |
| Dec 2014 | $275.50 M(+10.5%) | $67.40 M(-2.2%) | $275.50 M(+3.0%) |
| Sept 2014 | - | $68.90 M(-11.3%) | $267.60 M(+2.6%) |
| June 2014 | - | $77.70 M(+26.3%) | $260.70 M(+5.7%) |
| Mar 2014 | - | $61.50 M(+3.4%) | $246.60 M(-1.1%) |
| Dec 2013 | $249.30 M(+23.3%) | $59.50 M(-4.0%) | $249.30 M(+3.1%) |
| Sept 2013 | - | $62.00 M(-2.5%) | $241.80 M(+7.0%) |
| June 2013 | - | $63.60 M(-0.9%) | $225.90 M(+9.8%) |
| Mar 2013 | - | $64.20 M(+23.5%) | $205.70 M(+1.7%) |
| Dec 2012 | $202.20 M(+8.4%) | $52.00 M(+12.8%) | $202.20 M(+3.2%) |
| Sept 2012 | - | $46.10 M(+6.2%) | $196.00 M(+0.6%) |
| June 2012 | - | $43.40 M(-28.5%) | $194.90 M(-2.0%) |
| Mar 2012 | - | $60.70 M(+32.5%) | $198.90 M(+6.5%) |
| Dec 2011 | $186.60 M(+13.4%) | $45.80 M(+1.8%) | $186.70 M(+12.1%) |
| Sept 2011 | - | $45.00 M(-5.1%) | $166.60 M(+0.8%) |
| June 2011 | - | $47.40 M(-2.3%) | $165.30 M(+46.5%) |
| Mar 2011 | - | $48.50 M(+88.7%) | $112.80 M(+1.6%) |
| Dec 2010 | $164.50 M(-1.1%) | $25.70 M(-41.2%) | $111.00 M(-11.6%) |
| Sept 2010 | - | $43.70 M(-956.9%) | $125.50 M(-0.6%) |
| June 2010 | - | -$5.10 M(-110.9%) | $126.30 M(-28.5%) |
| Mar 2010 | - | $46.70 M(+16.2%) | $176.70 M(+6.1%) |
| Dec 2009 | $166.40 M(-10.6%) | $40.20 M(-9.7%) | $166.50 M(+0.1%) |
| Sept 2009 | - | $44.50 M(-1.8%) | $166.40 M(+6.9%) |
| June 2009 | - | $45.30 M(+24.1%) | $155.70 M(-7.8%) |
| Mar 2009 | - | $36.50 M(-9.0%) | $168.90 M(-9.3%) |
| Dec 2008 | $186.10 M(+18.2%) | $40.10 M(+18.6%) | $186.20 M(+7.0%) |
| Sept 2008 | - | $33.80 M(-42.2%) | $174.10 M(+4.2%) |
| June 2008 | - | $58.50 M(+8.7%) | $167.10 M(+5.9%) |
| Mar 2008 | - | $53.80 M(+92.1%) | $157.80 M(+0.1%) |
| Dec 2007 | $157.50 M(-0.7%) | $28.00 M(+4.5%) | $157.60 M(-6.9%) |
| Sept 2007 | - | $26.80 M(-45.5%) | $169.20 M(-3.5%) |
| June 2007 | - | $49.20 M(-8.2%) | $175.30 M(+2.4%) |
| Mar 2007 | - | $53.60 M(+35.4%) | $171.20 M(+7.9%) |
| Dec 2006 | $158.60 M(+31.2%) | $39.60 M(+20.4%) | $158.60 M(+2.7%) |
| Sept 2006 | - | $32.90 M(-27.1%) | $154.40 M(+4.6%) |
| June 2006 | - | $45.10 M(+10.0%) | $147.60 M(+12.0%) |
| Mar 2006 | - | $41.00 M(+15.8%) | $131.80 M(+9.0%) |
| Dec 2005 | $120.90 M(+44.6%) | $35.40 M(+35.6%) | $120.90 M(+14.7%) |
| Sept 2005 | - | $26.10 M(-10.9%) | $105.40 M(+8.1%) |
| June 2005 | - | $29.30 M(-2.7%) | $97.50 M(+5.6%) |
| Mar 2005 | - | $30.10 M(+51.3%) | $92.30 M(+10.4%) |
| Dec 2004 | $83.60 M | $19.90 M(+9.3%) | $83.60 M(-33.3%) |
| Sept 2004 | - | $18.20 M(-24.5%) | $125.30 M(+2.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2004 | - | $24.10 M(+12.6%) | $121.80 M(+4.1%) |
| Mar 2004 | - | $21.40 M(-65.3%) | $117.00 M(+6.2%) |
| Dec 2003 | $110.20 M(+33.1%) | $61.60 M(+319.0%) | $110.20 M(+41.1%) |
| Sept 2003 | - | $14.70 M(-23.8%) | $78.10 M(-0.4%) |
| June 2003 | - | $19.30 M(+32.2%) | $78.40 M(+1.6%) |
| Mar 2003 | - | $14.60 M(-50.5%) | $77.20 M(-7.2%) |
| Dec 2002 | $82.80 M(+10.8%) | $29.50 M(+96.7%) | $83.20 M(+24.0%) |
| Sept 2002 | - | $15.00 M(-17.1%) | $67.10 M(-4.7%) |
| June 2002 | - | $18.10 M(-12.1%) | $70.40 M(-5.1%) |
| Mar 2002 | - | $20.60 M(+53.7%) | $74.20 M(+1.9%) |
| Dec 2001 | $74.70 M(-1.6%) | $13.40 M(-26.8%) | $72.80 M(-3.2%) |
| Sept 2001 | - | $18.30 M(-16.4%) | $75.20 M(+15.3%) |
| June 2001 | - | $21.90 M(+14.1%) | $65.20 M(+19.6%) |
| Mar 2001 | - | $19.20 M(+21.5%) | $54.50 M(+18.2%) |
| Dec 2000 | $75.90 M(-25.7%) | $15.80 M(+90.4%) | $46.10 M(+4.5%) |
| Sept 2000 | - | $8.30 M(-25.9%) | $44.10 M(-13.4%) |
| June 2000 | - | $11.20 M(+3.7%) | $50.90 M(-14.9%) |
| Mar 2000 | - | $10.80 M(-21.7%) | $59.80 M(-9.9%) |
| Dec 1999 | $102.10 M(+5.3%) | $13.80 M(-8.6%) | $66.40 M(-32.6%) |
| Sept 1999 | - | $15.10 M(-24.9%) | $98.50 M(-1.0%) |
| June 1999 | - | $20.10 M(+15.5%) | $99.50 M(+3.9%) |
| Mar 1999 | - | $17.40 M(-62.1%) | $95.80 M(+48.1%) |
| Dec 1998 | $97.00 M(+3.4%) | $45.90 M(+185.1%) | $64.70 M(+80.2%) |
| Sept 1998 | - | $16.10 M(-1.8%) | $35.90 M(+10.5%) |
| June 1998 | - | $16.40 M(-219.7%) | $32.50 M(-2.4%) |
| Mar 1998 | - | -$13.70 M(-180.1%) | $33.30 M(-46.0%) |
| Dec 1997 | $93.80 M(+11.7%) | $17.10 M(+34.6%) | $61.70 M(+2.2%) |
| Sept 1997 | - | $12.70 M(-26.2%) | $60.40 M(+2.0%) |
| June 1997 | - | $17.20 M(+17.0%) | $59.20 M(+6.1%) |
| Mar 1997 | - | $14.70 M(-7.0%) | $55.80 M(+4.7%) |
| Dec 1996 | $84.00 M(+7.8%) | $15.80 M(+37.4%) | $53.30 M(+9.7%) |
| Sept 1996 | - | $11.50 M(-16.7%) | $48.60 M(+7.5%) |
| June 1996 | - | $13.80 M(+13.1%) | $45.20 M(0.0%) |
| Mar 1996 | - | $12.20 M(+9.9%) | $45.20 M(-6.4%) |
| Dec 1995 | $77.90 M(+11.0%) | $11.10 M(+37.0%) | $48.30 M(+0.2%) |
| Sept 1995 | - | $8.10 M(-41.3%) | $48.20 M(-3.4%) |
| June 1995 | - | $13.80 M(-9.8%) | $49.90 M(+1.8%) |
| Mar 1995 | - | $15.30 M(+39.1%) | $49.00 M(+4.0%) |
| Dec 1994 | $70.20 M(+11.3%) | $11.00 M(+12.2%) | $47.10 M(-1.7%) |
| Sept 1994 | - | $9.80 M(-24.0%) | $47.90 M(+1.7%) |
| June 1994 | - | $12.90 M(-3.7%) | $47.10 M(+4.0%) |
| Mar 1994 | - | $13.40 M(+13.6%) | $45.30 M(+10.2%) |
| Dec 1993 | $63.10 M(-0.3%) | $11.80 M(+31.1%) | $41.10 M(+9.6%) |
| Sept 1993 | - | $9.00 M(-18.9%) | $37.50 M(+3.0%) |
| June 1993 | - | $11.10 M(+20.7%) | $36.40 M(-2.2%) |
| Mar 1993 | - | $9.20 M(+12.2%) | $37.20 M(-5.6%) |
| Dec 1992 | $63.30 M(+172.8%) | $8.20 M(+3.8%) | $39.40 M(+567.8%) |
| Sept 1992 | - | $7.90 M(-33.6%) | $5.90 M(+7.3%) |
| June 1992 | - | $11.90 M(+4.4%) | $5.50 M(+323.1%) |
| Mar 1992 | - | $11.40 M(-145.1%) | $1.30 M(-208.3%) |
| Dec 1991 | $23.20 M(-47.2%) | -$25.30 M(-437.3%) | -$1.20 M(-104.9%) |
| Sept 1991 | - | $7.50 M(-2.6%) | $24.60 M(+7.9%) |
| June 1991 | - | $7.70 M(-13.5%) | $22.80 M(+9.1%) |
| Mar 1991 | - | $8.90 M(+1680.0%) | $20.90 M(-2.8%) |
| Dec 1990 | $43.90 M(-22.2%) | $500.00 K(-91.2%) | $21.50 M(-112.5%) |
| Sept 1990 | - | $5.70 M(-1.7%) | -$171.90 M(+58.9%) |
| June 1990 | - | $5.80 M(-38.9%) | -$108.20 M(+213.6%) |
| Mar 1990 | - | $9.50 M(-104.9%) | -$34.50 M(-195.6%) |
| Dec 1989 | $56.40 M(+14.4%) | -$192.90 M(-378.0%) | $36.10 M(-22.5%) |
| Sept 1989 | - | $69.40 M(-12.7%) | $46.60 M(+0.9%) |
| June 1989 | - | $79.50 M(-0.7%) | $46.20 M(+12.1%) |
| Mar 1989 | - | $80.10 M(-143.9%) | $41.20 M(+35.5%) |
| Dec 1988 | $49.30 M(+5.6%) | -$182.40 M(-364.3%) | $30.40 M(-45.6%) |
| Sept 1988 | - | $69.00 M(-7.4%) | $55.90 M(+27.3%) |
| June 1988 | - | $74.50 M(+7.5%) | $43.90 M(+17.7%) |
| Mar 1988 | - | $69.30 M(-144.2%) | $37.30 M(+24.7%) |
| Dec 1987 | $46.70 M(+2.6%) | -$156.90 M(-375.3%) | $29.90 M(-30.6%) |
| Sept 1987 | - | $57.00 M(-16.1%) | $43.10 M(0.0%) |
| June 1987 | - | $67.90 M(+9.7%) | $43.10 M(+9.1%) |
| Mar 1987 | - | $61.90 M(-143.1%) | $39.50 M(+28.2%) |
| Dec 1986 | $45.50 M(+28.2%) | -$143.70 M(-352.1%) | $30.80 M(-44.6%) |
| Sept 1986 | - | $57.00 M(-11.4%) | $55.60 M(+34.6%) |
| June 1986 | - | $64.30 M(+20.9%) | $41.30 M(+50.7%) |
| Mar 1986 | - | $53.20 M(-144.7%) | $27.40 M(+16.1%) |
| Dec 1985 | $35.50 M(+14.1%) | -$118.90 M(-378.5%) | $23.60 M(-4.1%) |
| Sept 1985 | - | $42.70 M(-15.3%) | $24.60 M(-0.4%) |
| June 1985 | - | $50.40 M(+2.0%) | $24.70 M(+11.3%) |
| Mar 1985 | - | $49.40 M(-141.9%) | $22.20 M(+7.8%) |
| Dec 1984 | $31.10 M | -$117.90 M(-375.5%) | $20.60 M(-85.1%) |
| Sept 1984 | - | $42.80 M(-10.6%) | $138.50 M(+44.7%) |
| June 1984 | - | $47.90 M(+0.2%) | $95.70 M(+100.2%) |
| Mar 1984 | - | $47.80 M | $47.80 M |
FAQ
- What is West Pharmaceutical Services annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for West Pharmaceutical Services?
- What is West Pharmaceutical Services annual EBITDA year-on-year change?
- What is West Pharmaceutical Services quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for West Pharmaceutical Services?
- What is West Pharmaceutical Services quarterly EBITDA year-on-year change?
- What is West Pharmaceutical Services TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for West Pharmaceutical Services?
- What is West Pharmaceutical Services TTM EBITDA year-on-year change?
What is West Pharmaceutical Services annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of WST is $813.30 M
What is the all time high annual EBITDA for West Pharmaceutical Services?
West Pharmaceutical Services all-time high annual earnings before interest, taxes, depreciation & amortization is $879.40 M
What is West Pharmaceutical Services annual EBITDA year-on-year change?
Over the past year, WST annual earnings before interest, taxes, depreciation & amortization has changed by +$4.90 M (+0.61%)
What is West Pharmaceutical Services quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of WST is $205.40 M
What is the all time high quarterly EBITDA for West Pharmaceutical Services?
West Pharmaceutical Services all-time high quarterly earnings before interest, taxes, depreciation & amortization is $259.10 M
What is West Pharmaceutical Services quarterly EBITDA year-on-year change?
Over the past year, WST quarterly earnings before interest, taxes, depreciation & amortization has changed by -$20.20 M (-8.95%)
What is West Pharmaceutical Services TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of WST is $744.40 M
What is the all time high TTM EBITDA for West Pharmaceutical Services?
West Pharmaceutical Services all-time high TTM earnings before interest, taxes, depreciation & amortization is $910.50 M
What is West Pharmaceutical Services TTM EBITDA year-on-year change?
Over the past year, WST TTM earnings before interest, taxes, depreciation & amortization has changed by -$56.10 M (-7.01%)